G. Ciurlia

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

L. Rostaing, N. Kamar, M. Essig, 2018, Advances in Therapy.

Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent.

H. Bisgaard, B. Chawes, A. Døssing, 2014, Respiratory medicine.

Pharmacokinetic comparison of inhaled fixed combination vs. the free combination of beclomethasone and formoterol pMDIs in asthmatic children.

H. Bisgaard, B. Chawes, A. Døssing, 2013, British journal of clinical pharmacology.

Pharmacokinetics of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide in adolescent and adult patients with asthma

P. Kuna, J. Jerzyńska, G. Ciurlia, 2022, Pharmacology research & perspectives.

A Randomized, Controlled Trial to Investigate the Efficacy of Nebulized Poractant Alfa in Premature Babies with Respiratory Distress Syndrome.

C. Dani, G. Balla, A. Lavizzari, 2022, The Journal of pediatrics.

A Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug–Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993

Luca Spaccapelo, A. Muraro, G. Ciurlia, 2016, European Journal of Drug Metabolism and Pharmacokinetics.

Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover study.

Dave Singh, M. Scuri, A. Muraro, 2017, Pulmonary pharmacology & therapeutics.